Long-term Oncologic and Financial Implications of Lung Cancer Screening

Jesper Johannes Holst Pedersen; Jens Benn Sørensen

doi:10.1016/j.thorsurg.2014.11.006

Long-term Oncologic and Financial Implications of Lung Cancer Screening

Jesper Johannes Holst Pedersen, Jens Benn Sørensen

Department of Clinical Medicine

2 Citations (Scopus)

Abstract

Benefits and risks of computed tomography lung cancer screening are discussed with specific focus on oncologic and financial issues. Earlier disease stage at diagnosis implies that more patients are treated surgically, but the changes in oncologic treatment will not be dramatic. The crucial issue for implementation of screening will be that it is cost effective. Preliminary data from the National Lung Screening Trial indicate that it is cost effective and comparable to screening for other major malignancies. Some future modifications in the computed tomography screening methodology are discussed.

Original language	English
Journal	Thoracic Surgery Clinics
Volume	25
Issue number	2
Pages (from-to)	223-9
Number of pages	7
ISSN	1547-4127
DOIs	https://doi.org/10.1016/j.thorsurg.2014.11.006
Publication status	Published - May 2015

Keywords

Cost-Benefit Analysis
Early Detection of Cancer
Health Care Costs
Humans
Lung Neoplasms
Mass Screening
Radiotherapy Dosage
Risk
Tomography, X-Ray Computed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.thorsurg.2014.11.006

Cite this

@article{778fc498ff4e4263aa3edec9fba7ae40,

title = "Long-term Oncologic and Financial Implications of Lung Cancer Screening",

abstract = "Benefits and risks of computed tomography lung cancer screening are discussed with specific focus on oncologic and financial issues. Earlier disease stage at diagnosis implies that more patients are treated surgically, but the changes in oncologic treatment will not be dramatic. The crucial issue for implementation of screening will be that it is cost effective. Preliminary data from the National Lung Screening Trial indicate that it is cost effective and comparable to screening for other major malignancies. Some future modifications in the computed tomography screening methodology are discussed.",

keywords = "Cost-Benefit Analysis, Early Detection of Cancer, Health Care Costs, Humans, Lung Neoplasms, Mass Screening, Radiotherapy Dosage, Risk, Tomography, X-Ray Computed",

author = "Pedersen, {Jesper Johannes Holst} and S{\o}rensen, {Jens Benn}",

year = "2015",

month = may,

doi = "10.1016/j.thorsurg.2014.11.006",

language = "English",

volume = "25",

pages = "223--9",

journal = "Thoracic Surgery Clinics",

issn = "1547-4127",

publisher = "W.B.Saunders Co.",

number = "2",

}

TY - JOUR

T1 - Long-term Oncologic and Financial Implications of Lung Cancer Screening

AU - Pedersen, Jesper Johannes Holst

AU - Sørensen, Jens Benn

PY - 2015/5

Y1 - 2015/5

N2 - Benefits and risks of computed tomography lung cancer screening are discussed with specific focus on oncologic and financial issues. Earlier disease stage at diagnosis implies that more patients are treated surgically, but the changes in oncologic treatment will not be dramatic. The crucial issue for implementation of screening will be that it is cost effective. Preliminary data from the National Lung Screening Trial indicate that it is cost effective and comparable to screening for other major malignancies. Some future modifications in the computed tomography screening methodology are discussed.

AB - Benefits and risks of computed tomography lung cancer screening are discussed with specific focus on oncologic and financial issues. Earlier disease stage at diagnosis implies that more patients are treated surgically, but the changes in oncologic treatment will not be dramatic. The crucial issue for implementation of screening will be that it is cost effective. Preliminary data from the National Lung Screening Trial indicate that it is cost effective and comparable to screening for other major malignancies. Some future modifications in the computed tomography screening methodology are discussed.

KW - Cost-Benefit Analysis

KW - Early Detection of Cancer

KW - Health Care Costs

KW - Humans

KW - Lung Neoplasms

KW - Mass Screening

KW - Radiotherapy Dosage

KW - Risk

KW - Tomography, X-Ray Computed

U2 - 10.1016/j.thorsurg.2014.11.006

DO - 10.1016/j.thorsurg.2014.11.006

M3 - Journal article

C2 - 25901566

SN - 1547-4127

VL - 25

SP - 223

EP - 229

JO - Thoracic Surgery Clinics

JF - Thoracic Surgery Clinics

IS - 2

ER -

Long-term Oncologic and Financial Implications of Lung Cancer Screening

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this